×
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
NYSE:CLVT

Clarivate Stock Forecast, Price & News

$14.03
-0.65 (-4.43%)
(As of 06/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$14.00
$14.87
50-Day Range
$12.80
$16.83
52-Week Range
$11.71
$27.81
Volume
5.43 million shs
Average Volume
5.79 million shs
Market Capitalization
$9.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.40
30 days | 90 days | 365 days | Advanced Chart

Receive CLVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter.

CLVT Stock Forecast (MarketRank)

Overall MarketRank

2.77 out of 5 stars

Computer And Technology Sector

104th out of 937 stocks

Data Processing & Preparation Industry

3rd out of 114 stocks

Analyst Opinion: 3.3Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 2.5 5 -4 -3 -2 -1 -
Clarivate logo

About Clarivate (NYSE:CLVT)

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

CLVT Stock News Headlines

Clarivate (NYSE:CLVT) Releases FY 2022 Earnings Guidance
See More Headlines

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Fax
N/A
Employees
11,353
Year Founded
N/A

Company Calendar

Last Earnings
5/09/2022
Today
6/29/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$19.40
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+38.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.6
Research Coverage
5 Analysts

Profitability

Net Income
$-270.45 million
Pretax Margin
-5.53%

Debt

Sales & Book Value

Annual Sales
$1.88 billion
Cash Flow
$1.51 per share
Book Value
$16.46 per share

Miscellaneous

Free Float
505,220,000
Market Cap
$9.44 billion
Optionable
Optionable
Beta
0.85














Clarivate Frequently Asked Questions

Should I buy or sell Clarivate stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clarivate in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" Clarivate stock.
View analyst ratings for Clarivate
or view top-rated stocks.

What is Clarivate's stock price forecast for 2022?

5 analysts have issued 12 month price targets for Clarivate's stock. Their CLVT stock forecasts range from $16.00 to $28.00. On average, they expect Clarivate's share price to reach $19.40 in the next year. This suggests a possible upside of 38.3% from the stock's current price.
View analysts' price targets for Clarivate
or view top-rated stocks among Wall Street analysts.

How has Clarivate's stock performed in 2022?

Clarivate's stock was trading at $23.52 on January 1st, 2022. Since then, CLVT stock has decreased by 40.3% and is now trading at $14.03.
View the best growth stocks for 2022 here
.

When is Clarivate's next earnings date?

Clarivate is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Clarivate
.

How were Clarivate's earnings last quarter?

Clarivate Plc (NYSE:CLVT) announced its quarterly earnings results on Monday, May, 9th. The company reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.01. The company earned $662.20 million during the quarter, compared to analysts' expectations of $662.84 million. Clarivate had a negative net margin of 4.77% and a positive trailing twelve-month return on equity of 4.89%. The company's revenue was up 54.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.13 EPS.
View Clarivate's earnings history
.

What guidance has Clarivate issued on next quarter's earnings?

Clarivate issued an update on its FY 2022 earnings guidance on Monday, June, 27th. The company provided earnings per share (EPS) guidance of $0.85-$0.95 for the period, compared to the consensus EPS estimate of $0.90. The company issued revenue guidance of $2.80 billion-$2.88 billion, compared to the consensus revenue estimate of $2.80 billion.

Who are Clarivate's key executives?

Clarivate's management team includes the following people:
  • Mr. Jerre L. Stead, Exec. Chairman & CEO (Age 79, Pay $1.07M)
  • Mr. Jonathan M. Collins, Exec. VP & CFO (Age 42, Pay $32.57k)
  • Mr. Richard Hanks, Exec. Officer (Age 58, Pay $698.52k) (LinkedIn Profile)
  • Mr. Mukhtar Ahmed, Advisor (Age 54, Pay $830.66k) (LinkedIn Profile)
  • Mr. Gordon Samson, Chief Product Officer (Age 56, Pay $686.49k)
  • Mr. Steen Lomholt-Thomsen, Chief Revenue Officer (Age 58, Pay $1.13M)
  • Mr. Michael Easton, Sr. VP of Fin. & Chief Accounting Officer (Age 49)
  • Mr. Stefano Maestri, Chief Technology Officer
  • Mr. William E. Graff, Chief Information Officer
  • Mr. Mark J. Donohue, Head of Investor Relations

What is Clarivate's stock symbol?

Clarivate trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLVT."

Who are Clarivate's major shareholders?

Clarivate's stock is owned by many different retail and institutional investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (4.21%), Select Equity Group L.P. (3.70%), BlackRock Inc. (3.14%), State Street Corp (1.65%), Clarkston Capital Partners LLC (1.59%) and Farallon Capital Management LLC (1.30%). Company insiders that own Clarivate stock include Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, Richard Hanks and Richard Roedel.
View institutional ownership trends for Clarivate
.

Which major investors are selling Clarivate stock?

CLVT stock was sold by a variety of institutional investors in the last quarter, including Select Equity Group L.P., American Century Companies Inc., Eaton Vance Management, Williams Jones Wealth Management LLC., TD Asset Management Inc., National Bank of Canada FI, Anchor Capital Advisors LLC, and Bank of New York Mellon Corp. Company insiders that have sold Clarivate company stock in the last two years include Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, and Richard Hanks.
View insider buying and selling activity for Clarivate
or view top insider-selling stocks.

Which major investors are buying Clarivate stock?

CLVT stock was acquired by a variety of institutional investors in the last quarter, including Clarkston Capital Partners LLC, Farallon Capital Management LLC, Rivulet Capital LLC, Confluence Investment Management LLC, Sunriver Management LLC, Sumitomo Mitsui Trust Holdings Inc., Timucuan Asset Management Inc. FL, and BlackRock Inc..
View insider buying and selling activity for Clarivate
or or view top insider-buying stocks.

How do I buy shares of Clarivate?

Shares of CLVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Clarivate's stock price today?

One share of CLVT stock can currently be purchased for approximately $14.03.

How much money does Clarivate make?

Clarivate (NYSE:CLVT) has a market capitalization of $9.44 billion and generates $1.88 billion in revenue each year. The company earns $-270.45 million in net income (profit) each year or ($0.39) on an earnings per share basis.

How many employees does Clarivate have?

Clarivate employs 11,353 workers across the globe.

How can I contact Clarivate?

Clarivate's mailing address is 160 Blackfriars Road, London X0, SE1 8EZ. The official website for Clarivate is www.clarivate.com. The company can be reached via phone at 442074334000 or via email at [email protected].

This page (NYSE:CLVT) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.